The Global Market for Migraine Drugs - Opportunity Analysis & Industry Forecast to 2025 - ResearchAndMarkets.com

August 24, 2018

DUBLIN--(BUSINESS WIRE)--Aug 24, 2018--The “Migraine Drugs Market by Type, Route of Administration, and Distribution Channel - Global Opportunity Analysis and Industry Forecast, 2018-2025” report has been added to ResearchAndMarkets.com’s offering.

The global migraine drugs market was valued at $1,713 million in 2017, and is expected to reach $2,190 million by 2025, growing at a CAGR of 3.1% from 2018 to 2025.

Rise in awareness among patients for migraine treatment & prevention, rapid increase in female population, and surge in prevalence of migraine drive the growth of the global migraine drugs market. However, side effects associated with migraine drugs limit the market growth. On the contrary, growth opportunities in the developing nations and emerging new therapies for migraine treatment are expected to present opportunities for the market growth during the forecast period.

Key Benefits

This report entails a detailed quantitative analysis of the overall market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of the global migraine drugs market. Market size and estimations are based on comprehensive analysis of the applications and developments in the industry. An in-depth analysis based on region is provided to understand the regional market and facilitate the strategic business planning. The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

Profiles for:

Key Players

Abbott Laboratories Allergan PLC AstraZeneca Eisai Co. Ltd. Endo International PLC GlaxoSmithKline PLC Impax Laboratories Johnson & Johnson Merck & Co. Pfizer Inc.

Other Players

Novartis International AG Teva Pharmaceutical Industries Limited Sanofi SA

Key Topics Covered

Chapter 1: Introduction

Chapter 2: Executive Summary

Chapter 3: Market Overview

Chapter 4: Migraine Drugs Market, by Type

Chapter 5: Migraine Drugs Market, by Route of Administration

Chapter 6: Migraine Drugs Market, by Distribution Channel

Chapter 7: Migraine Drugs Market, by Region

Chapter 8: Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/fsv2vs/the_global_market?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180824005084/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs,Analgesics



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/24/2018 04:55 AM/DISC: 08/24/2018 04:55 AM


Update hourly